Short peptides (typically 2-4 amino acids) developed primarily in Russian research, theorized to support specific organ systems. Examples include Cartalax (cartilage), Livagen (liver), and Pinealon (brain). Clinical evidence is limited to Russian-language publications.
"Bioregulator" is filed under Basics in the PeptideAtlas glossary, alongside 12 other terms in that group.
The term applies directly to 12 compound profiles here: Pinealon (evidence D), Thymalin (evidence C), Cartalax (evidence D), Ovagen (evidence D), Thymagen (evidence D), Vesugen (evidence D), Thymogen (evidence D), Cerluten (evidence F), and others. Each profile states the strength of the human evidence rather than only what the compound is claimed to do.
1 other glossary entry refer to this term in their own definition, which is usually the fastest way to see how it is used in practice.
A proton-coupled peptide transporter (SLC15A1) in the intestinal epithelium that absorbs di- and tripeptides from digested food. It is the primary mechanism by which short oral peptides and bioregulators may achieve systemic absorption. Larger peptides cannot use this transporter.
The building blocks of peptides and proteins. There are 20 standard amino acids that combine in various sequences to form peptides.
A short chain of amino acids (typically 2-50 amino acids) linked by peptide bonds. Shorter than proteins but with diverse biological activities.
The chemical bond formed between two amino acids when the carboxyl group of one reacts with the amino group of another, releasing water.
Compounds where this applies: Pinealon, Thymalin, Cartalax, Ovagen, Thymagen, Vesugen, Thymogen, Cerluten, Kristagen, Zhenoluten, Prostatilen, Retinalamin.
Terms that reference this one: PepT1 Transporter.
More Basics terms: Amino Acid, Peptide, Peptide Bond, Sequence, Analogue, Neuropeptide, Signaling Peptide, D-Retro-Inverso, Cyclization, PEGylation, Acylation, DAC (Drug Affinity Complex).